Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Which TNBC Patients Benefit From Adjuvant Chemo?
TOPLINE: Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a 5-year DFS rate of 96.9% compared with 79.4% in the control group. METHODOLOGY: In some…
English